blindness and tirzepatide Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Weight-loss drugs like semaglutide and

Synergistic Stack #2: Injury Recovery & Healing For accelerated healing of muscle, tendon, or joint injuries: IGF-1 LR3: 30 mcg once daily for 4 weeks BPC-157: 250 mcg 2x/day for 4-6 weeks (use our BPC-157 calculator) TB-500: 5 mg 2x/week for 4-6 weeks Synergy: IGF-1 LR3 promotes muscle cell growth, BPC-157 supports vascular and epithelial healing, TB-500 enhances cellular migration and tissue repair

The choice between oral and injectable semaglutide often hinges on patient preferences, lifestyle factors, and practical considerations beyond clinical efficacy

GLP-1 is an incr et in , i.e., hormone that incr eases insul in secretion

Sometimes the answer is not stronger medication but treating the root cause